Germany
Germany · page 2
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- Patient Access
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
- Medical Cannabis
Cannabis Use Among Teens Flat After German Partial Legalisation, But Medical Market Continues Rapid Expansion
Germany’s Cannabis Act (CanG) has not led to an increase in use among young people, according to new peer-reviewed research adding to the growing body of evidence contradicting the harms predicted by the reform’s critics.
- Prescribers & Clinics
Cantourage Bets on Own Brand to Defend Flower Margins
Cantourage Group SE has announced the launch of its first proprietary medical cannabis brand for the German market, in a meaningful pivot for the distributor.
- Data & Analysis
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
- Data & Analysis
Public Data is No Longer Enough to Understand the German Medical Cannabis Market
Germany’s medical cannabis market, which has long been the engine powering Europe’s wider market growth, once again finds itself in a state of flux.
- UK & Europe
Germany’s Drug Commissioner Backs Cannabis Pilot Projects in Break With CDU Party Line
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the country’s booming cannabis industry has been bracing for a crackdown.
- Events
Berlin 2026: European Cannabis M&A Finds its Footing
As the European cannabis conference season gets started, industry experts, lawmakers, regulators and business owners are facing greater mainstream scrutiny than ever before.
- Industry Trends
Germany’s Cannabis Reform Shows No Signs of Harm its Critics Predicted, Government Mandated Data Shows
On the second anniversary of Germany’s landmark Cannabis Act (CanG) coming into force, the most comprehensive data and analysis of its impact to date has been published.
- Data & Analysis
Stable Consumption, Falling Arrests: Germany’s Cannabis Landscape 2-Years On
Next week will mark the second anniversary of the implementation of Germany’s landmark Cannabis Act (CanG), which came into force on April 01, 2024.
- Industry Trends
Germany’s Medical Cannabis Product Range Quadruples as Prices Fall 30%
Business of Cannabis is excited to announce the launch of German Cannabis Intel: Insights & Market Data, the inaugural report in our new quarterly series in partnership with Grünhorn.
- Industry Trends
Deals, Courts and Coalition Splits: Germany’s Cannabis Market Braces for Change
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
